Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (58)
2025 (697)
2024 (743)
2023 (750)
2022 (797)
2021 (829)
2020 (649)
2019 (542)
2018 (803)
2017 (914)
2016 (860)
2015 (649)
2014 (589)
2013 (461)
2012 (331)
2011 (191)
2010 (70)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (10057)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Essand M
JSON
CSV
XLSX
TXT
Family name
Essand
Given name
Magnus
Initials
M
ORCID
ORCID
0000-0002-9725-0422
Affiliations
Department of Immunology Genetics and Pathology Science for Life Laboratory Uppsala University Uppsala 752 37 Sweden
8 publications
PubMed
DOI
Crossref
Trogocytosis of chimeric antigen receptors between T cells is regulated by their transmembrane domains.
Barbera S
,
Schuiling MJA
,
Sanjaya NA
, ...,
Essand M
,
Dimberg A
Sci Immunol
10
(103) eado2054 [2025-01-31; online 2025-01-31]
DOI
Crossref
Enhanced Cellular Uptake through Nanotopography‐Induced Macropinocytosis
Aramesh M
,
Yu D
,
Essand M
,
Persson C
Adv. Funct. Mater.
34
(28) - [2024-07-00; online 2024-03-13]
DOI
Crossref
Nanotopography boosts cellular uptake by inducing macropinocytosis
Aramesh M
,
Yu D
,
Essand M
,
Persson C
-
-
(-) - [2023-12-20; online 2023-12-20]
DOI
Crossref
VLDLR mediates alphavirus neuroinvasion through the blood-cerebrospinal fluid barrier
Martikainen M, Lugano R, Pietilä I, ..., Dimberg A,
Essand M
-
-
(-) - [2023-10-30; online 2023-10-30]
PubMed
DOI
Crossref
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.
Sarén T
,
Ramachandran M
,
Gammelgård G
, ...,
Enblad G
,
Essand M
Clin. Cancer Res.
29
(20) 4139-4152 [2023-10-13; online 2023-08-04]
PubMed
DOI
Crossref
CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers.
Jin C, Ma J,
Ramachandran M
,
Yu D
,
Essand M
Nat Biomed Eng
6
(7) 830-841 [2022-07-00; online 2022-04-04]
PubMed
DOI
Crossref
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma.
van Hooren L
, Vaccaro A, Ramachandran M, ...,
Essand M
,
Dimberg A
Nat Commun
12
(1) 4127 [2021-07-05; online 2021-07-05]
DOI
Crossref
Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma
van Hooren L, Vaccaro A, Ramachandran M, ...,
Essand M
,
Dimberg A
-
-
(-) - [2021-01-06; online 2021-01-06]
SciLifeLab Data Centre
Publications
9.5.1